Does quality of life of prostate cancer patients differ by stage and treatment?

Scandinavian Journal of Public Health

Volumn 41, Issue 1, 2013, Pages 58-64

  Vanagas, Giedrius ^a   Mickevičienė, Aušra ^a   Ulys, Albertas ^b  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

cancer stage; prostate cancer; prostate cancer treatment; quality of life

Indexed keywords

AGED; ARTICLE; CANCER STAGING; CROSS-SECTIONAL STUDY; HUMAN; LITHUANIA; MALE; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT OUTCOME;

AGED; CROSS-SECTIONAL STUDIES; HUMANS; LITHUANIA; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84872956322     PISSN: 14034948     EISSN: 16511905     Source Type: Journal    
DOI: 10.1177/1403494812467503     Document Type: Article

References (30)

1. Arcangeli S. Pinzi V. Arcangeli G. Epidemiology of prostate cancer and treatment remarks. World J Radiol 2012;4:241–6.
2. World Health Organization and International Agency for Research on Cancer. Cancer incidence and mortality worldwide in 2008. France: Globocan, 2011. Available at http://globocaniarcfr.
3. Jemal A. Siegel R. Ward E. et al. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–49.
4. Smailytė G.A.B. Cancer in Lithuania in 2009. Vilnius: Petro ofsetas, 2011.
5. Schroder F.H. Screening for prostate cancer (PC) – an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Urol Oncol 2008;26:533–41.
6. Bryant R.J. Hamdy F.C. Screening for prostate cancer: an update. Eur Urol 2008;53:37–44.
7. Chou R. Le Fevre M.L. Prostate cancer screening – the evidence, the recommendations, and the clinical implications. JAMA 2011;306:2721–2.
8. Singh J. Trabulsi E.J. Gomella L.G. Is there an optimal management for localized prostate cancer? Clin Interv Aging 2010;5:187–97.
9. Schwartz R.S. Clinical decisions. Management of prostate cancer – polling results. N Engl J Med 2009;360:e4.
10. Vanagas G. Padaiga Z. Bagdonas E. Cost-utility analysis of methadone maintenance treatment: a methodological approach. Subst Use Misuse 2006;41: 87–101.
11. Mickeviciene A. Vanagas G. Ulys A. et al. Factors affecting health-related quality of life in prostate cancer patients. Scand J Urol Nephrol 2012;46:180–7.
12. Roeloffzen E.M. Lips I.M. van Gellekom M.P. et al. Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer. Int J Radiat Oncol Biol Phys 2010;76:1054–60.
13. Hayes J.H. Ollendorf D.A. Pearson S.D. et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA 2010;304: 2373–80.
14. Niezgoda H.E. Pater J.L. A validation study of the domains of the core EORTC quality of life questionnaire. Qual Life Res 1993;2:319–25.
15. Ringdal G.I. Ringdal K. Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res 1993;2:129–40.
16. Krahn M. Bremner K.E. Tomlinson G. et al. Responsiveness of disease-specific and generic utility instruments in prostate cancer patients. Qual Life Res 2007;16:509–22.
17. European Organisation for Research and Treatment of Cancer. EORTC Groups Website. Available at http://groups.eortc.be (2012).
18. Crott R. Briggs A. Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences. Eur J Health Econ 2010;11:427–34.
19. Reeve B.B. Stover A.M. Jensen R.E. et al. Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: a population-based study. Cancer 2012 ;118(22):5679–87.
20. Reeve B.B. Potosky A.L. Smith A.W. et al. Impact of cancer on health-related quality of life of older Americans. J Natl Cancer Inst 2009;101:860–8.
21. Singh J. Trabulsi E.J. Gomella L.G. The quality-of-life impact of prostate cancer treatments. Curr Urol Rep 2010;11:139–46.
22. Hinz A. Krauss O. Stolzenburg J.U. et al. Anxiety and depression in patients with prostate cancer and other urogenital cancer: a longitudinal study. Urol Oncol 2009;27: 367–72.
23. Litwin M.S. Gore J.L. Kwan L. et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 2007;109:2239–47.
24. Namiki S. Arai Y. Health-related quality of life in men with localized prostate cancer. Int J Urol 2010;17:125–38.
25. White W.M. Sadetsky N. Waters W.B. et al. Quality of life in men with locally advanced adenocarcinoma of the prostate: an exploratory analysis using data from the CaPSURE database. J Urol 2008;180:2409–13.
26. Burnet K.L. Parker C. Dearnaley D. et al. Does active surveillance for men with localized prostate cancer carry psychological morbidity? BJU Int 2007;100:540–3.
27. Shah N.L. Sanda M. Health-related quality of life in treatment for prostate cancer: looking beyond survival. Support Cancer Ther 2004;1:230–6.
28. Hinz A. Krauss O. Hauss J.P. et al. Anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care (Engl) 2010;19:522–9.
29. Gacci M. Simonato A. Masieri L. et al. Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy. Health Qual Life Outcomes 2009;7:94.
30. Klabunde C.N. Reeve B.B. Harlan L.C. et al. Do patients consistently report comorbid conditions over time?: results from the prostate cancer outcomes study. Med Care 2005;43:391–400.